Celcuity Inc.
Celcuity Inc. (CELC) Financial Performance & Income Statement Overview
Review Celcuity Inc. (CELC) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Celcuity Inc. (CELC) Income Statement & Financial Overview
Review Celcuity Inc. CELC income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $35254.00 | $0.00 | $31115.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$31115.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $32.23M | $33.47M | $27.59M | $22.50M |
| SG&A Expenses | $3.91M | $2.96M | $2.47M | $1.79M |
| Operating Expenses | $36.13M | $36.39M | $30.06M | $24.28M |
| Total Costs & Expenses | $0.00 | $36.52M | $30.06M | $24.28M |
| Interest Income | $2.32M | $3.05M | $3.61M | $2.82M |
| Interest Expense | $3.18M | $3.28M | $3.34M | $2.26M |
| Depreciation & Amortization | $0.00 | $35254.00 | $34021.00 | $31115.00 |
| EBITDA | -$36.13M | -$33.34M | -$26.41M | -$21.43M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$36.13M | -$36.43M | -$30.06M | -$24.28M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$864000.00 | -$222910.00 | $268110.00 | $561266.00 |
| Income Before Tax | -$37.00M | -$36.65M | -$29.79M | -$23.72M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | -$3.00 | $0.00 | $0.00 |
| Net Income | -$37.00M | -$36.65M | -$29.79M | -$23.72M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.86 | -$0.85 | -$0.70 | -$0.62 |
| Diluted EPS | -$0.86 | -$0.85 | -$0.70 | -$0.62 |
| Weighted Avg Shares Outstanding | $43.05M | $42.87M | $42.79M | $38.44M |
| Weighted Avg Shares Outstanding (Diluted) | $43.05M | $42.87M | $42.79M | $38.44M |
Over the past four quarters, Celcuity Inc. demonstrated steady revenue growth, increasing from $0.00 in Q2 2024 to $0.00 in Q1 2025. Operating income reached -$36.13M in Q1 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$36.13M, reflecting operational efficiency. Net income dropped to -$37.00M, with EPS at -$0.86. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan